European defense one year on: Money is not the problem, capacity (and delivery) are| Listen on Anghami

Oct 22

A double-edged code: How AI is reshaping the global wealth landscape

This week on the Tomorrow podcast, we dive into the Allianz Global Wealth Report 2026. The big picture: Global financial assets jumped to a record EUR268.4trn in 2025, up +8.6% from the previous year. But it’s not because households are not saving more – markets accounted for 4 o ... Show More

9m 56s

Jul 2026

Half-Time Outlook 2026-27: AI holds the score, growth slows to +2.5%

In our last episode before the summer break, Aria and Bob dive into Allianz Research's Half-Time Outlook for 2026-2027. How is the energy shock from the Middle East conflict playing out? Has inflation been knocked out? Tune in to find out! You can read the full report on our webs ... Show More

4m 32s

Jun 2026

Ten years after Brexit: Resilience without revival

The UK is now looking for its seventh prime minister in 10 years after Keir Starmer’s resignation earlier this week. Interestingly, this week also marks 10 years since the Brexit vote, which roiled markets and divided forecasters. In this episode, Aria and Bob look at which proje ... Show More

5m 21s

Oct 2024

Hot shot: the wider promise of weight-loss jabs

<p>First they treated diabetes. Then obesity. Now <a href="https://www.economist.com/leaders/2024/10/24/its-not-just-obesity-drugs-like-ozempic-will-change-the-world?utm_campaign=a.io&utm_medium=audio.podcast.np&utm_source=theintelligence&utm_content=discovery.content.anonymous.t ... Show More

23m 58s

Sep 2023

2. The drug behind Europe's most valuable company

How much harm has been done by decades of governments investing too little? Is buy-now-pay-later causing misery or joy for young shoppers? Are supermarkets cutting prices fast enough? Is Novo Nordisk’s anti obesity wonder drug Semaglutide the most important pharmaceutical discove ... Show More

56m 39s

Dec 2023

Pfizer’s Second Gut Punch Shows Pitfalls of Weight-Loss Pills

Bloomberg News Health Reporter Madison Muller explains how Pfizer’s second weight-loss setback this year is a warning sign that breaking into the lucrative obesity market isn’t going to be easy. Cory Klippsten, CEO at Swan Bitcoin, shares his crypto outlook for 2024. Benjamin Wo ... Show More

42m 33s

Aug 2023

Divergent Economic Outcomes: Japan, China, Europe and the US

A lively and informative discussion between Ayesha and Mayhem about the economic picture in Japan, Europe, and the US, as well as what we’re looking out for as we navigate the rest of 2023. Get full access to MacroVisor at macrovisor.substack.com/subscribe

37m 52s

European defense one year on: Money is n...